We are live on
!
Find out more
BTW
Boston Trust Walden Portfolio holdings
AUM
$13.1B
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$14B
AUM Growth
+$333M
(+2.4%)
Cap. Flow
-$46.3M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
384
New
12
Increased
132
Reduced
160
Closed
10
Avg Time Held
28.8
quarters
Top 10 Avg Time Held
18.6
quarters
Top 20 Avg Time Held
21.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hubbell
HUBB
|
+$25.1M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$25M |
| 3 |
NVIDIA
NVDA
|
+$23.3M |
| 4 |
Acuity Brands
AYI
|
+$22.6M |
| 5 |
Zimmer Biomet
ZBH
|
+$20.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$34.6M |
| 2 |
Visa
V
|
+$33.8M |
| 3 |
Hanover Insurance
THG
|
+$28.8M |
| 4 |
Analog Devices
ADI
|
+$26M |
| 5 |
Toro Company
TTC
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.83% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 14.26% |
| 4 | Healthcare | 12.8% |
| 5 | Consumer Discretionary | 9.27% |
Similar funds
MG
GLA
VLKIM
BCI
EIG
PCM
WHG
CRM
Boston Trust Walden's Q2 2025 Portfolio in Review
As of Q2 2025, Boston Trust Walden held 384 positions worth $14B, up 2.4% from $13.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Trust Walden's Q2 2025 filing shows 12 new, 132 increased, 160 reduced and 10 closed positions. Its largest new stake was Amalgamated Financial: 544,044 shares worth $17M. The largest sale was UnitedHealth, an estimated $34.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Boston Trust Walden's largest Q2 2025 buy was Amalgamated Financial: 544,044 shares worth $17M.
- Boston Trust Walden added most to Hubbell in Q2 2025, an estimated $25.1M increase.
- Boston Trust Walden's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $34.6M.
- Boston Trust Walden fully exited Helmerich & Payne in Q2 2025, selling an estimated $21.8M.
- Boston Trust Walden's ten largest holdings make up 18% of its $14B portfolio in Q2 2025.
- Boston Trust Walden opened 12 new positions and closed 10 in Q2 2025.
- Boston Trust Walden's portfolio value rose 2.4% quarter-over-quarter to $14B.
Based on Boston Trust Walden's 13F filing for Q2 2025, filed 28 Jul 2025.